Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 65, Issue 20, Pages 14180-14200Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c01373J.Med
Keywords
-
Categories
Funding
- French-German ANR/DFG [ANR-17-CE11-0048]
- Agence Nationale de la Recherche [Ti756/5-1]
- Deutsche Forschungsgemeinschaft [ANR-15-IDEX-0002]
- ANR project Glyco@Alps [ANR-17-EURE-0003]
- Labex ARCANE
- DAAD [716311]
- European Union through the European Social Fund
- Ambassade de France en Allemagne
- European Research Council [TTU 09.719]
- German Centre for Infection Research (DZIF)
- CBH-EUR-GS
- [ANR-AAPG-2017]
- [POWR.03.02.00-00-I026/16]
- Agence Nationale de la Recherche (ANR) [ANR-15-IDEX-0002] Funding Source: Agence Nationale de la Recherche (ANR)
Ask authors/readers for more resources
This study identified beta-fucosyl amides as high-affinity ligands for LecB, providing a basis for future development into antibacterial drugs.
nosa causes severe infections mainly in immunocompromised or cystic fibrosis patients and is able to resist antimicrobial treatments. The extracellular lectin LecB plays a key role in bacterial adhesion to the host and biofilm formation. For the inhibition of LecB, we designed and synthesized a set of fucosyl amides, sulfonamides, and thiourea derivatives. Then, we analyzed their binding to LecB in competitive and direct binding assays. We identified beta-fucosyl amides as unprecedented high-affinity ligands in the two-digit nanomolar range. X-ray crystallography of one alpha- and one beta anomer of N-fucosyl amides in complex with LecB revealed the interactions responsible for the high affinity of the beta-anomer at atomic level. Further, the molecules showed good stability in murine and human blood plasma and hepatic metabolism, providing a basis for future development into antibacterial drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available